DUO-MEDIHALER Drug Patent Profile
✉ Email this page to a colleague
When do Duo-medihaler patents expire, and when can generic versions of Duo-medihaler launch?
Duo-medihaler is a drug marketed by 3M and is included in one NDA.
The generic ingredient in DUO-MEDIHALER is isoproterenol hydrochloride; phenylephrine bitartrate. There are seventeen drug master file entries for this compound. Additional details are available on the isoproterenol hydrochloride; phenylephrine bitartrate profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for DUO-MEDIHALER?
- What are the global sales for DUO-MEDIHALER?
- What is Average Wholesale Price for DUO-MEDIHALER?
Summary for DUO-MEDIHALER
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 73 |
| Patent Applications: | 3,882 |
| DailyMed Link: | DUO-MEDIHALER at DailyMed |
US Patents and Regulatory Information for DUO-MEDIHALER
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3m | DUO-MEDIHALER | isoproterenol hydrochloride; phenylephrine bitartrate | AEROSOL, METERED;INHALATION | 013296-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
